Evaluate your board’s compensation levels and practices against the market.

Biopharma companies with share constraints can adopt several best practice provisions to maximize the chance of success.

If increasing demands on directors’ time has led to questions about the appropriateness of the board pay program, here are some ideas to consider.

Six tangible steps boards can take to maximize value and minimize CEO succession risk

Significant industry dynamics are driving a number of similar client questions. We offer broad data to provide guidance and market context.

While the size of the grant and facts of the case are highly idiosyncratic, there are important takeaways for boards and compensation committees.

Periodically stress-testing your bank’s CIC agreements can eliminate surprises. Here is a step-by-step guide.

While private companies may lack access to the strong allure of public company equity, there are clear ways to compete for—and win—high caliber talent.

Five-year data from Pearl Meyer’s Executive Compensation and Benchmarking Survey show clear advantages for the largest companies.

Directors frequently ask about increasing their holdings. Here are two ways companies can structure additional choice beyond simple open-market purchases.

Establishing executive compensation performance goals remains a challenge. Focusing on core principles can help when the answers aren’t clear.

Sixty-nine public and private bank institutions shared their views on executive compensation changes and expectations for 2024.